Alambic Investment Management’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,917
Closed -$149K 418
2018
Q4
$149K Sell
12,917
-20,256
-61% -$346K 0.06% 265
2018
Q3
$718K Sell
33,173
-30,118
-48% -$570K 0.57% 57
2018
Q2
$998K Buy
63,291
+6,851
+12% +$108K 0.27% 141
2018
Q1
$1.06M Sell
56,440
-24,910
-31% -$491K 0.15% 216
2017
Q4
$1.42M Buy
81,350
+37,130
+84% +$512K 0.17% 206
2017
Q3
$662K Buy
44,220
+28,505
+181% +$448K 0.07% 317
2017
Q2
$292K Sell
15,715
-40,564
-72% -$705K 0.04% 458
2017
Q1
$950K Buy
56,279
+17,797
+46% +$355K 0.12% 274
2016
Q4
$819K Buy
38,482
+15,482
+67% +$318K 0.15% 234
2016
Q3
$420K Buy
23,000
+15,100
+191% +$340K 0.1% 316
2016
Q2
$229K Buy
+7,900
New +$220K 0.06% 430

Other funds holding ARA

Alambic Investment Management's ARA Position: Q1 2019 in Review

Alambic Investment Management sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2019, closing a stake of 12,917 shares — an estimated $149K sold.

Alambic Investment Management first reported a position in ARA in Q2 2016 and held it in 11 quarters. The position peaked at $1.42M in Q4 2017. 68 funds tracked by Wall St. Rank hold ARA as of Q1 2019.

  • Alambic Investment Management reported no remaining American Renal Associates Holdings, Inc position as of Q1 2019 after selling out during the quarter.
  • Alambic Investment Management sold 12,917 American Renal Associates Holdings, Inc shares in Q1 2019, an estimated $149K.
  • Alambic Investment Management first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 11 quarters.
  • Alambic Investment Management's American Renal Associates Holdings, Inc position peaked at $1.42M in Q4 2017.
  • 68 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2019.

Based on Alambic Investment Management's 13F filing for Q1 2019, filed 9 May 2019.